# US 2010/0168852 A1 · Brush Copolymers

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0168852 A1
- Document ID: US20100168852A1
- Status: Published application
- Kind: A1
- Application number: 12/641,473
- Filed: 2009-12-18
- Published: 2010-07-01
- Earliest claimed: 2008-12-30
- Assignees: Bausch & Lomb Incorporated
- Inventors: David Paul Vanderbilt; Paul L. Valint, JR.
- Web page: https://patentgrep.com/patent/US20100168852A1

## CPC

- G02B 1/043: {Contact lenses}
- A61L 27/34: Macromolecular materials
- C08F 290/046: {Polymers of unsaturated carboxylic acids or derivatives thereof}
- A61F 2/1613: {having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus}
- G02B: OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C08F: MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

Brush copolymers containing (a) monomeric units derived from an ethylenically unsaturated monomer containing one or more boronic acid moieties and; and (b) monomeric units derived from an ethylenically unsaturated-containing hydrophilic macromonomer are disclosed.

## Claims

### Claim 1

A brush copolymer comprising (a) monomeric units derived from an ethylenically unsaturated monomer containing one or more boronic acid moieties and; and (b) monomeric units derived from an ethylenically unsaturated-containing hydrophilic macromonomer.

### Claim 2 (depends on 1)

The brush copolymer of claim 1, having a backbone of the monomeric units derived from an ethylenically unsaturated monomer containing one or more boronic acid moieties; and bristles of the monomeric units derived from an ethylenically unsaturated-containing hydrophilic macromonomer.

### Claim 3 (depends on 1)

The brush copolymer of claim 1, wherein the ethylenically unsaturated monomer containing one or more boronic acid moieties comprises an ethylenically unsaturated containing aryl boronic acid.

### Claim 4 (depends on 1)

The brush copolymer of claim 1, wherein the ethylenically unsaturated monomer containing one or more boronic acid moieties is selected from the group consisting of 4-vinylphenylboronic acid, 3-methacrylamidophenylboronic acid, 3-acrylamidophenylboronic acid and mixtures thereof.

### Claim 5 (depends on 1)

The brush copolymer of claim 1, wherein the hydrophilic macromonomer comprises units derived from a hydrophilic monomer selected from the group consisting of an unsaturated carboxylic acid, vinyl lactam, amide, polymerizable amine, vinyl carbonate, vinyl carbamate, oxazolone monomer and mixtures thereof.

### Claim 6 (depends on 1)

The brush copolymer of claim 1, wherein the hydrophilic macromonomer is made using atom transfer radical polymerization (ATRP) or reversible addition-fragmentation chain transfer (RAFT) polymerization.

### Claim 7 (depends on 1)

The brush copolymer of claim 1, wherein the hydrophilic macromonomer has a number average molecular weight of about 500 to about 200,000.

### Claim 8 (depends on 1)

The brush copolymer of claim 1, further comprising monomeric units derived from an ethylenically unsaturated monomer containing a tertiary-amine moiety.

### Claim 9 (depends on 1)

The brush copolymer of claim 1, further comprising monomeric units derived from an ethylenically unsaturated monomer containing a hydrophilic moiety capable of rendering the brush copolymer water-soluble.

### Claim 10 (depends on 9)

The brush copolymer of claim 9, wherein the hydrophilic moiety is derived from a hydrophilic monomer selected from the group consisting of N-vinyl pyrrolidone, N-vinyl-N-methyl acetamide, N,N-dimethyl methacrylamide, N,N-dimethylacrylamide, and mixtures thereof.

### Claim 11 (depends on 2)

The brush copolymer of claim 2, wherein the backbone further comprises monomeric units derived from an ethylenically unsaturated monomer containing a tertiary-amine moiety; and monomeric units derived from an ethylenically unsaturated monomer containing a hydrophilic moiety capable of rendering the copolymer water-soluble.

### Claim 12 (depends on 1)

The brush copolymer of claim 1, comprising about 1 to about 20 mole percent of the boronic acid-containing monomeric units, about 1 to about 20 mole percent of the monomeric units derived from an ethylenically unsaturated hydrophilic macromonomer, about 1 to about 20 mole percent of monomeric units derived from an ethylenically unsaturated monomer containing a tertiary-amine moiety, and about 40 to about 90 mole percent of monomeric units derived from an ethylenically unsaturated monomer containing a hydrophilic moiety capable of rendering the copolymer water-soluble.

### Claim 13

A biomedical device having a coating on a surface thereof, the coating comprising a brush copolymer comprising (a) monomeric units derived from an ethylenically unsaturated monomer containing one or more boronic acid moieties and; and (b) monomeric units derived from an ethylenically unsaturated-containing hydrophilic macromonomer.

### Claim 14 (depends on 13)

The biomedical device of claim 13, wherein the brush copolymer has a backbone of the monomeric units derived from an ethylenically unsaturated monomer containing one or more boronic acid moieties; and bristles of the monomeric units derived from an ethylenically unsaturated-containing hydrophilic macromonomer.

### Claim 15 (depends on 13)

The biomedical device of claim 13, wherein the ethylenically unsaturated monomer containing one or more boronic acid moieties comprises an ethylenically unsaturated containing aryl boronic acid.

### Claim 16 (depends on 13)

The biomedical device of claim 13, wherein the ethylenically unsaturated monomer containing one or more boronic acid moieties is selected from the group consisting of 4-vinylphenylboronic acid, 3-methacrylamidophenylboronic acid, 3-acrylamidophenylboronic acid and mixtures thereof.

### Claim 17 (depends on 13)

The biomedical device of claim 13, wherein the hydrophilic macromonomer comprises units derived from a hydrophilic monomer selected from the group consisting of an unsaturated carboxylic acid, vinyl lactam, amide, polymerizable amine, vinyl carbonate, vinyl carbamate, oxazolone monomer and mixtures thereof.

### Claim 18 (depends on 13)

The biomedical device of claim 13, wherein the hydrophilic macromonomer is made using ATRP or RAFT polymerization.

### Claim 19 (depends on 13)

The biomedical device of claim 13, wherein the hydrophilic macromonomer has a number average molecular weight of about 500 to about 200,000.

### Claim 20 (depends on 13)

The biomedical device of claim 13, wherein the brush copolymer further comprises monomeric units derived from an ethylenically unsaturated monomer containing a tertiary-amine moiety.

### Claim 21 (depends on 13)

The biomedical device of claim 13, wherein the brush copolymer further comprises monomeric units derived from an ethylenically unsaturated monomer containing a hydrophilic moiety capable of rendering the copolymer water-soluble.

### Claim 22 (depends on 21)

The biomedical device of claim 21, wherein the hydrophilic moiety is derived from a hydrophilic monomer selected from the group consisting of N-vinyl pyrrolidone, N-vinyl-N-methyl acetamide, N,N-dimethyl methacrylamide, N,N-dimethylacrylamide, and mixtures thereof.

### Claim 23 (depends on 14)

The biomedical device of claim 14, wherein the backbone further comprises monomeric units derived from an ethylenically unsaturated monomer containing a tertiary-amine moiety; and monomeric units derived from an ethylenically unsaturated monomer containing a hydrophilic moiety capable of rendering the copolymer water-soluble.

### Claim 24 (depends on 13)

The biomedical device of claim 13, wherein the brush copolymer comprises about 1 to about 20 mole percent of the boronic acid-containing monomeric units, about 1 to about 20 mole percent of the monomeric units derived from an ethylenically unsaturated hydrophilic macromonomer, about 1 to about 20 mole percent of monomeric units derived from an ethylenically unsaturated monomer containing a tertiary-amine moiety, and about 40 to about 90 mole percent of monomeric units derived from an ethylenically unsaturated monomer containing a hydrophilic moiety capable of rendering the copolymer water-soluble.

### Claim 25 (depends on 13)

The biomedical device of claim 13, wherein the biomedical device is an ophthalmic lens.

### Claim 26 (depends on 25)

The biomedical device of claim 25, wherein the ophthalmic lens is a contact lens or an intraocular lens.

### Claim 27

A method for inhibiting adhesion of bacteria to a surface of a biomedical device is provided, the method comprising (a) providing a biomedical device having a coating on at least a portion of a surface thereof, the coating comprising a brush copolymer comprising (i) monomeric units derived from an ethylenically unsaturated monomer containing one or more boronic acid moieties and; and (ii) monomeric units derived from an ethylenically unsaturated-containing hydrophilic macromonomer; and (b) inserting the biomedical device in the eye of a patient.

### Claim 28 (depends on 27)

The method of claim 27, wherein the biomedical device is an ophthalmic lens.
